Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cancer is believed to arise from stem cells, but mechanisms that limit the acquisition of mutations and tumor development have not been well defined. We show that a +4 stem cell (SC) in the gastric antrum, marked by expression of Cck2r (a GPCR) and Delta-like ligand 1 (DLL1), is a label-retaining cell that undergoes predominant asymmetric cell division. This +4 antral SC is Notch1low/ Numb+ and repressed by signaling from gastrin-expressing endocrine (G) cells. Chemical carcinogenesis of the stomach is associated with loss of G cells, increased symmetric stem cell division, glandular fission, and more rapid stem cell lineage tracing, a process that can be suppressed by exogenous gastrin treatment. This hormonal suppression is associated with a marked reduction in gastric cancer mutational load, as revealed by exomic sequencing. Taken together, our results show that gastric tumorigenesis is associated with increased symmetric cell division that facilitates mutation and is suppressed by GPCR signaling.
Pubmed ID: 32142681
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Open source Java based image processing software program designed for scientific multidimensional images. ImageJ has been transformed to ImageJ2 application to improve data engine to be sufficient to analyze modern datasets.
View all literature mentionsA biotechnology corporation that uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions.
View all literature mentionsJava toolset for working with next generation sequencing data in the BAM format.
View all literature mentionsThis polyclonal targets RFP
View all literature mentionsThis monoclonal targets E-Cadherin (24E10) Rabbit mAb
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets GFP
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets H+/K+ ATPase beta (C-4)
View all literature mentionsThis polyclonal secondary targets IgY (H+L)
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis polyclonal targets GAST, CCK
View all literature mentionsThis polyclonal targets anti-Trefoil Factor 2 (TFF2) antibody
View all literature mentionsThis polyclonal targets Chromogranin A antibody
View all literature mentionsThis monoclonal targets BrdU
View all literature mentionsThis polyclonal targets Mouse Mucin 5AC
View all literature mentionsThis unknown targets
View all literature mentionsThis polyclonal targets Gastrin
View all literature mentionsThis polyclonal targets DCLK1
View all literature mentionsThis recombinant monoclonal targets Ki67
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets activated Notch1
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Catenin, beta
View all literature mentionsThis monoclonal targets E-CADHERIN
View all literature mentionsThis monoclonal targets Somatostatin antibody [8.F.258]
View all literature mentionsThis polyclonal secondary targets IgY (H+L)
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name 129-Cckbrtm1Kpn/J from IMSR.
View all literature mentionsMus musculus with name B6.129-Gasttm1Lcs/J from IMSR.
View all literature mentions